MALLORY GRAY: Open Payments
NPI 1255963252 · MOORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$954 in 51 payments from 10 companies in 2025. Trend: 2023 $431 · 2024 $640 · 2025 $954
Food & beverage: $954
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $385 |
| AstraZeneca Pharmaceuticals LP | 9 | $156 |
| Collegium Pharmaceutical, Inc. | 4 | $91 |
| Vanda Pharmaceuticals Inc. | 3 | $76 |
| Corcept Therapeutics | 3 | $68 |
| PFIZER INC. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Organon LLC | 1 | $35 |
| Novo Nordisk Inc | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: QULIPTA, VRAYLAR, FARXIGA, UBRELVY, Jornay PM, FANAPT, Korlym, CAPLYTA.
Industry payments across OK — which companies pay providers there.
